Human exposure to volatile organic pollutants: Implications for indoor air studies

Annual Review of Energy and the Environment

Volumn 26, Issue , 2001, Pages 269-301

  Wallace, Lance A ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Breath analysis; Indoor air quality; Personal monitors; VOC

Indexed keywords

AIR POLLUTION; AIR QUALITY; ENVIRONMENTAL IMPACT; MONITORING; RESPIRATORY MECHANICS;

BREATH ANALYSIS; ENVIRONMENTAL POLLUTANTS; ENVIRONMENTAL REGULATIONS; PERSONAL MONITORS;

VOLATILE ORGANIC COMPOUNDS;

EID: 0035701130     PISSN: 10563466     EISSN: None     Source Type: Journal    
DOI: 10.1146/annurev.energy.26.1.269     Document Type: Article

References (167)

1. Concepts of human exposure to air pollution
2. Total human exposure: An emerging science focuses on humans as receptors of environmental pollution
3. Total human exposure: Basic concepts, EPA field studies, and future research needs
4. Analytical studies for the U.S. environmental protection agency
5. Personal monitors: A state-of-the-art survey
6. The TEAM study: Summary analysis
7. Measuring human exposure to carbon monoxide in Washington, D.C., and Denver, Colorado, during the winter of 1982-83
8. Personal exposure to airborne particles and metals: Results from the particle TEAM study in riverside, CA
9. A decade of studies of human exposure: What have we learned?
10. Personal exposures, indoor-outdoor relationships and breath levels of toxic air pollutants measured for 355 persons in New Jersey
11. Applications of Tenax trapping to cigarette smoking
12. Volatile organic compounds in 12 California office buildings: Classes, concentrations, and sources
13. Inhalation transfer factors for air pollution health risk assessment
14. Exposure efficiency: Concept and application to perchloroethylene exposure from dry cleaners
15. Air pollution and the energy ladder in Asian cities
16. Air pollution: Assessing total exposure in the United States
17. Exposure trading: An approach to more efficient air pollution control
18. Design of surveys for residential and personal monitoring of hazardous substances
19. Monitoring individual exposure: Measurement of volatile organic compounds in breathing-zone air, drinking water, and exhaled breath
20. Personal exposure to volatile organic compounds. I. Direct measurement in breathing-zone air, drinking water, food, and exhaled breath
21. The California TEAM study: Breath concentrations and personal exposures to 26 volatile compounds in air and drinking water of 188 residents of Los Angeles, Antioch, and Pittsburg, CA
22. The Los Angeles TEAM study: Personal exposures, indoor-outdoor air concentrations, and breath concentrations of 25 volatile organic compounds
23. Microenvironmental and personal measurements of methyl-tertiary butyl ether associated with automobile use activities
24. Personal exposures to particulate matter: Instruments and methodologies of PTEAM
25. Occurrence of volatile organic compounds in the air of 500 Homes in the Federal Republic of Germany
26. The German environmental survey 1990/92 GerESII: A representative population study
27. Sampling design, response rates, and analysis weights for the National Human Exposure Assessment Survey NHEXAS in EPA region V
28. National Human Exposure Assessment Survey NHEXAS study in Arizona-Introduction and preliminary results
29. A longitudinal investigation of solid food-based dietary exposure to selected elements
30. Particulate matter and manganese exposures for residents of Toronto, Canada
31. Activity patterns of Californians: Use of and proximity to indoor pollutant sources
32. Exposures to benzene and other volatile organic compounds from active and passive smoking
33. Use of passive samplers for the determination of gaseous organic substances in indoor air at low concentration levels
34. Collection and analysis of hazardous organic emissions
35. Modification and evaluation of a thermally desorbable passive sampler for volatile organic compounds in air
36. A multi-sorbent sampler for volatile organic compounds in indoor air
37. Individual volatile organic compound prevalence and concentration in 56 buildings of the building survey and evaluation BASE study
38. Sample integrity of trace level volatile organic compounds in ambient air stored in summa polished canisters
39. Intercomparison of sampling techniques for toxic organic compounds in indoor air
40. Influence of indoor climate on the sick building syndrome in an office environment
41. Measurement of volatile organic compounds in exhaled breath as collected in evacuated electropolished canisters
42. Collection of a single alveolar exhaled breath for volatile organic compounds analysis
43. Exhaled human breath measurement method for assessing exposure to halogenated volatile organic compounds
44. Sampling for organic chemicals in air
45. A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans
46. A physiologically based toxicokinetic description of the metabolism of inhaled gases and vapors: Analysis at steady state
47. Recent advances in measuring exhaled breath and estimating exposure and body burden for volatile organic compounds (VOCs)
48. Breath measurements as VOC biomarkers: EPA's experience in field and chamber studies
49. Characterization of human expired air: A promising investigation and diagnostic technique
50. Measurement of chemical inhalation exposure in urban populations in the presence of endogenous effluents
51. Elimination kinetics of volatile organics in humans using breath measurements
52. Breath sampling for environmental carcinogens: Methods of analysis and exposure measurement
53. Breath measurements in a clean-air chamber to determine "wash-out" times for volatile organic compounds at environmental concentrations
54. Residence times of volatile organic compounds in human breath following exposure to air pollutants at near-normal environmental concentrations
55. Elimination of volatile organic compounds in breath after exposure to occupational and environmental microenvironments
56. Reconstructing week-long exposures to volatile organic compounds using physiologically-based pharmacokinetic models
57. A canister-based method for collection and GC/MS analysis of volatile organic compounds in human breath
58. A device for sampling human alveolar breath for the measurement of expired volatile organic compounds
59. Kinetics of low-level volatile organic compounds in breath. II: Relationship between concentrations measured in exposure air and alveolar air
60. Kinetics of low-level volatile organic compounds in breath. I: Experimental design and data quality
61. Elimination of volatile organic compounds in breath after exposure to occupational and environmental microenvironments
62. A linear model relating breath concentrations to environmental exposures: Application to a chamber study of four volunteers exposed to volatile organic chemicals
63. A four compartment model relating breath concentrations to low-level chemical exposures: Application to a chamber study of five subjects exposed to nine VOCs
64. Household exposure to benzene from showering with gasoline-contaminated ground water
65. Body burden measurements and models to assess inhalation exposure to methyl tertiary butyl ether (MTBE)
66. Alveolar breath sampling and analysis to assess trihalomethane exposures during competitive swimming training
67. Development of a physiologically based pharmacokinetic model for chloroform
68. Continuous real-time breath analysis for the measurement of half-lives of expired volatile organic compounds
69. Effect of water temperature on dermal exposure to chloroform
70. Tetrachloroethylene in exhaled air of persons living near pollution sources
71. Plasma chloroform concentrations in swimmers using indoor swimming pools
72. Benzene in the breath and blood of normal people and occupationally exposed workers
73. Determining volatile organic compounds in human blood from a large sample population by using purge and trap gas chromatography-mass spectrometry
74. Blood concentrations of volatile organic compounds in a nonoccupationally exposed US population and in groups with suspected exposure
75. Measurement of volatile organic compounds in human blood
76. Polychlorinated biphenyls PCBs and dichlorodiphenyl dichloroethane DDE in human milk
77. An investigation of indoor air contamination in residences above dry cleaners
78. An exposure and risk assessment regarding the presence of tetrachloroethene in human breastmilk
79. An assessment of tetrachloroethene in breastmilk
80. Experimental human exposure to perchloroethylene
81. Dermal absorption of dilute aqueous chloroform, trichloroethylene, and tetrachloroethylene in hairless guinea pigs
82. Pharmacokinetics of the dermal route of exposure to volatile organic chemicals in water: A computer simulation model
83. Evaluation of dermal and respiratory chloroform exposure in humans
84. Routes of chloroform exposure and body burden from showering with contaminated tap water
85. Chloroform exposure and the health risk associated with multiple uses of chlorinated tap water
86. A solution to the sick-building mystery
87. Volatilization of chemicals from tap water to indoor air while showering with contaminated water
88. Volatilization rates from water to indoor air: Phase II. EPA final rep., grant CR824228-01
89. Physiologically based pharmacokinetic modeling of the temperature-dependent dermal absorption of chloroform by humans following bath water exposures
90. Effect of dry-cleaned clothes on tetrachloroethylene levels in indoor air, personal air, and breath for residents of several New Jersey homes
91. The influence of personal activities on exposure to volatile organic compounds
92. Exposure to methylene chloride from controlled use of a paint remover in a residence
93. Cancer risk in adulthood from early life exposure to parents' smoking
94. Bladder cancer, drinking water sources, and tap water consumption: A case-control study
95. Unfinished business: A comparative assessment of environmental problems
96. The carcinogenic risk of some organic vapors indoors: A theoretical survey
97. Comparison of risks from outdoor and indoor exposure to toxic chemicals
98. How to measure and evaluate VOC emissions from building products: A perspective
99. Photocopiers and indoor air pollution
100. VOC emissions after building renovations: Traditional and less common indoor air contaminants, potential sources, and reported health complaints
101. A carcinogenic potency database of the standardized results of animal bioassays
102. Indoor air quality and work environment survey: EPA headquarters' buildings
103. Indoor air quality and work environment survey: EPA headquarters' building
104. Indoor air quality and work environment survey: EPA headquarters buildings
105. Indoor air quality and work environment survey: EPA headquarters buildings
106. Association of personal and workplace characteristics with health, comfort, and odor: A survey of 3948 office workers in three buildings
107. Perception of indoor air quality among government employees in Washington, DC
108. Valuing the health benefits of clean air
109. The role of potential immunogenic components of dust "MOD" in the sick building syndrome
110. Influence of personal characteristics, job-related factors, and stress factors on the sick building syndrome
111. The "sick" building syndrome in the office environment: The Danish Town Hall Study
112. Human reactions during controlled exposures to low concentrations of organic gases and vapours known as normal indoor air pollutants
113. Indoor air qquality in relation to sensory irritation due to volatile organic compounds
114. Human reactions to low concentrations of volatile organic compounds
115. The sick buildings-a sub-population among the problem buildings?
116. Neurobehavioral and sensory irritation effects of controlled exposure to a complex mixture of volatile organic compounds
117. Sensory and other neurogenic effects of exposures to airborne office dust
118. House dust in seven Danish offices
119. Characterization of indoor air quality and "sick buildings"
120. Health and indoor climate complaints of 7043 office workers in 61 buildings in the Netherlands
121. The office illness project in northern Sweden. Part III: A case-referent study of sick building syndrome (SBS) in relation to building characteristics and ventillation
122. Development of new volatile organic compound VOC exposure metrics and their relationship to sick building syndrome symptoms
123. The experience of the yale occupational and environmental medicine clinics with multiple chemical sensitivities, 1986-91
124. The identification of polar organic compounds found in consumer products and their toxicological properties
125. Estimates of improved productivity and health from better indoor environments
126. Potential reactions among indoor pollutants
127. The influence of ventilation on reactions among indoor pollutants: Dynamic modeling and experimental observations
128. Volatile organic compounds-sources, measurements, emissions, and the impact on indoor air quality
129. Are we measuring the relevant indoor pollutants?
130. Formation of strong airway irritants in a model mixture of +-α-pinene/ozone
131. Formation of strong airway irritants in terpene/ozone mixtures
132. 3 with a series of monoterpenes and related compounds at 296 +2K
133. Preliminary assessment of the occurrence and possible sources of MTBE in groundwater in the United States, 1993-1994
134. Formation of haloforms during chlorination of natural waters
135. Haloforms in drinking water
136. Chlorination reactions of fulvic acids in natural waters
137. Halogenated hydrocarbons in New Orleans drinking water and blood plasma
138. National organics reconnaissance survey for halogenated organics
139. AWWARF trihalomethane survey
140. Human exposures to volatile halogenated organic chemicals in indoor and outdoor air
141. Inhalation exposure in the home to volatile organic contaminants of drinking water
142. Human exposure to volatile organic compounds in household tap water: The indoor inhalation pathway
143. Linking a PBPK model for chloroform with measured breath concentrations in showers: Implications for dermal exposure models
144. The transfer of trichloroethylene TCE from a shower to indoor air: Experimental measurements and their implications
145. Household exposures to drinking water disinfection by-products: Whole blood trihalomethane levels
146. Residues of volatile halocarbons in food using headspace gas chromatography
147. Human exposure and body burden for chloroform and other trihalomethanes